Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00043706 (ClinicalTrials.gov)	May 2002	12/8/2002	Safety, Tolerability, and Pharmacokinetics of CAT-192 (HumanAnti-TGF-Beta1 Monoclonal Antibody) in P ...	A Phase 1/2 Double Blind, Placebo Controlled, Randomized, Dose Ranging, Repeat Dose Study to Assess ...	Systemic Sclerosis;Scleroderma	Drug: Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody	Genzyme, a Sanofi Company	Cambridge Antibody Technology	Completed	18 Years	75 Years	Both		Phase 1/Phase 2	United States

First Previous1Next Last